We are driven by clinical questions rather than specific biomarker classes or technologies. Hence, we are using a range of sophisticated omics technologies for biomarker identification and validation. Going forward, these technologies will also be used for diagnostic testing services provided by our lab in Cologne, Germany and potentially also by a future US reference laboratory. For our final IVD products we rely on established IVD technologies with widely used instrument platforms where we partner with established industry players.